Uterine fibroids are one of the most common tumor diseases in women, accounting for 20% to 25% of the female population. There are diverse ongoing procedures for uterine fibroids to treat profuse menstruation, menstrual pain increase, size increase, subfertility, postmenopausal size increase and others.
Introduction
http://dx.doi.org/10.6118/jmm.2016.22.2.94 the existing 3 to 4 ports used in the previous laparoscope operation. 9, 10 However, more non-invasive techniques are sought after to avoid the risk of general anesthesia, longer hospitalization and recovery period. Recently, as a non-invasive technique, HIFU also gets the limelight as a non-invasive treatment technique of adenomyosis in subfertility patients, which has had no effective therapy. HIFU technique is reported to promote the relief of symptoms due to adenomyosis. 11, 12 Also, studies have been going on about the impaired implantation and habitual miscarriage in subfertility cases due to adenomyosis. 13, 14 HIFU treatment is divided into ultrasound imageguided HIFU (USgHIFU) and magnetic resonance imaging Materials and Methods
Study subject and method
This study investigated 157 patients who had received Table 2 ).
The post-operative SSS began to decrease fast to record, 72% in Month 1 and 45% in Month 3 (Table 3 ). In Month 6, however, the level was observed as high as 76%. This is deemed because many patients were not followed more than In 6 cases, hysteroscopic myomectomy was performed; in 4 cases, mirena insertion; in 2 cases, laparoscopic myomectomy; and in 1 case, laparoscopic hysterectomy.
Among the patients receiving uterine fibroids ablation based on MRI-guided HIFU, uterine stimulant was used in parallel in 39 cases (Table 4) . When the uterine stimulant was used, the group showed statistically significantly lower 127.76 ± 53.63 minutes) (Fig. 3) . The NPV ratio was also found higher in the uterine stimulant-using group, indicating significantly higher therapeutic effectiveness Concerning the correlation between Funaki type of uterine fibroid and average sonication power, it was found that the closer to Type I, the lower the sonication power was with statistical significance (spearman correlation coefficient 0.305). Regarding the correlation between treatment hours and NPV ratio, shorter treatment hours and higher NPV ratio were observed with statistical significance. The 145  129  123  113  107  98  80  73  67  60  55  49  42  33  8   154  145  129  123  113  107  98  80  73  67  60  55  49  42  33  8   Freqeuncy   4  4  5  3  2   1  2 Using uterotonics (1 yes, 2 no) Fig. 3 . Correlation between average sonication power, average treatment time, and using with uterotonics.* *Spearman correlation coefficient were 0.320 between the average sonication power and using or not using with uterotonics, -0.344 between treatment time and using or not using with uterotonics.
spearman correlation coefficient was 0.185, and correlation coefficient was -0.320, respectively (Table 5 ; Fig. 4 Re-intervention showed no statistically significant result.
When the NPV ratio was classified into 25% or lower, 25% to 50%, 50% to 75%, and 75% or higher; it showed no correlation with average sonication power and treatment (Table 7) . and HIFU. 20, 21 Of them, HIFU is advantageous as it can be applied to large-sized lesion or multiple lesions; repeated treatment application is possible; its treatment process can be observed during and after operation and its effectiveness can be assessed; and it does not require anesthesia and skin incision. In this sense, HIFU can be viewed as the most non-invasive technique while keeping the uterus unremoved (Fig. 5) .
HIFU treatment mechanism is divided into thermal effect and non-thermal effect such as cavitation. Thermal effect is generated by irreversible apoptosis through coagulative necrosis caused by raising temperature to at least 56 o C human body is exposed to high intensity ultrasonic waves, the sound pressure effect of sound wave is known to make intracellular moisture into fine bubbles and if the bubbles grow larger enough to cause resonance, they suddenly burst and generate high pressure shock wave to destroy tissues. 23 The Sonalleve HIFU system employs equivalent minutes (EM) unit as the standard for the biological effect of heat.
Between 0 and 30 EM, it recognizes no thermal damage. Kim et al. 24 explained that the higher the uterine fibroids' T2-weighted signal, the higher the cellularity; and the better the perfusion, the higher the vascularity. Thus, they viewed it was difficult to perform HIFU treatment. In the case of hypercellularity and hypervascular fibroids, they said HIFU could be hardly implemented in over 2 cm-thick subcutaneous fat layer; and in the case of hypocellularity and hypovascular fibroids, it would be hard in over 2.5 to 3 cm subcutaneous fat layer.
In in Month 3. In Month 6, however, the level went up back to 76%. This is deemed because the patients with symptom recovery were hardly followed and most of the patients followed for 6 months after the operation had accompanied adenomyosis, and others to experience only minor recovery.
Uterine fibroid volume reduction in Month 1 was 42%; Month 3, 35%; and Month 6, 25%. The closer to Funaki Type I, the larger the reduction was.
Concerning the study on HIFU treatment using uterine stimulant in parallel, Zhang et al. 27 reported that, in adenomyosis cases, observed significantly shorter high intensity ultrasound treatment duration along with high, NPV ratio, concluding that uterine stimulant use was effective in ablating adenomyosis. Regarding uterine fibroids, Huang et al. 28 measured the sonication energy necessary to reach 60 o C in MRgFUS and reported its significant decrease when using uterine stimulant together. But no clinical study has conducted. In this present study, when uterine stimulant was utilized in parallel, HIFU intensity was measured significantly lower and the treatment duration was also found shorter (Fig. 4) . The NPV ratio was found higher in group using uterine stimulant and SSS change ratio in post-operative Month 3 was also significantly lower to conclude high therapeutic effectiveness of using uterine stimulant together.
In this study, as the Funaki Type of uterine fibroid was closer to Type I, sonication power grew significantly lower; treatment hours grew shorter; and NPV ratio rose higher.
( Longer follow-up was not conducted to observe more about re-intervention.
It seems necessary for subsequent study to unify dependent variables, follow forward-looking strategy, conduct a long-term follow-up, and research the safety of MRgFUS for women with adenomyosis and who desire pregnancy.
